University of Illinois
Chicago IL
MD - Medicine
1971University of Wisconsin
Madison WI
BS - Liberal Arts
1967N6-methyladenosine reader YTHDF2 in cell state transition and antitumor immunity.
N6-methyladenosine reader YTHDF2 in cell state transition and antitumor immunity. RNA. 2024 Dec 24.
PMID: 39719324Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference.
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference. Oncoimmunology. 2025 Dec; 14(1):2432726.
PMID: 39696783YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production.
YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production. J Clin Invest. 2024 Dec 02; 134(23).
PMID: 39325547Nanoscale Mixed-Ligand Metal-Organic Framework for X-ray Stimulated Cancer Therapy.
Nanoscale Mixed-Ligand Metal-Organic Framework for X-ray Stimulated Cancer Therapy. J Am Chem Soc. 2024 Dec 04; 146(48):33149-33158.
PMID: 39565960Bifunctional Metal-Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio-Immunotherapy.
Bifunctional Metal-Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio-Immunotherapy. Angew Chem Int Ed Engl. 2024 Oct 07; e202417027.
PMID: 39375150Multifunctional Nanomaterials Mediate Cholesterol Depletion for Cancer Treatment.
Multifunctional Nanomaterials Mediate Cholesterol Depletion for Cancer Treatment. Angew Chem Int Ed Engl. 2024 Nov 11; 63(46):e202412844.
PMID: 39146242Two decades of advances in clinical oncology - lessons learned and future directions.
Two decades of advances in clinical oncology - lessons learned and future directions. Nat Rev Clin Oncol. 2024 Nov; 21(11):771-780.
PMID: 39354161Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance.
Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance. Clin Cancer Res. 2024 Oct 01; 30(19):4450-4463.
PMID: 38691100Digitonin-Loaded Nanoscale Metal-Organic Framework for Mitochondria-Targeted Radiotherapy-Radiodynamic Therapy and Disulfidptosis.
Digitonin-Loaded Nanoscale Metal-Organic Framework for Mitochondria-Targeted Radiotherapy-Radiodynamic Therapy and Disulfidptosis. Adv Mater. 2024 Sep 10; e2405494.
PMID: 39252688Radiotherapy, immunity, and immune checkpoint inhibitors.
View All Publications
Radiotherapy, immunity, and immune checkpoint inhibitors. Lancet Oncol. 2024 Aug; 25(8):e352-e362.
PMID: 39089313
People
Ralph R. Weichselbaum, MD
-
Chair of Radiation and Cellular Oncology
Daniel K. Ludwig Distinguished Service Professor of Radiation and Cellular Oncology
Committee on Cancer Biology - Websites: Research Network Profile
- Contact: rrweichs@uchicago.edu
- Graduate Program: Cancer Biology